On February 12, 2024, Skye Bioscience, Inc., closed the transaction. The company has raised $49,991,010 from 11 investors. The company paid sales commission of $3,499,371 in the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.05 USD | -1.63% | +6.45% | +343.01% |
May. 10 | Skye Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 23 | Skye Bioscience, Inc.(NasdaqGM:SKYE) added to NASDAQ Transportation Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+343.01% | 338M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- EMBI Stock
- News Skye Bioscience, Inc.
- Skye Bioscience, Inc. announced that it has received $49.99101 million in funding